Citation Impact
Citing Papers
NSAID-analgesia, pain control and morbidity in cardiothoracic surgery
2006
Regulatory mechanisms of microRNA expression
2016
The epidemiology of venous thromboembolism
2016
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
2012 Standout
An Association between Atherosclerosis and Venous Thrombosis
2003
Analysis of Observational Studies in the Presence of Treatment Selection Bias
2007
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals
2007
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Venous thromboembolism: disease burden, outcomes and risk factors
2005
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInköping Study on Thrombosis (LIST) – A 7-year follow-up
2012 StandoutNobel
Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case–control study
2014
Perioperative Management of Antithrombotic Therapy
2012 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
Statins and the risk of idiopathic venous thromboembolism
2002
Risk factors and clinical impact of postoperative symptomatic venous thromboembolism
2007
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis
2009
Risk Factors of Cerebral Vein and Sinus Thrombosis
2007
A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
2009
Data Resource Profile: The Danish National Prescription Registry
2016 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
2015 Standout
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study
2012 Standout
HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women
2004
Antithrombotic Therapy for VTE Disease
2012 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Executive Summary
2012 Standout
The Danish National Patient Registry: a review of content, data quality, and research potential
2015 Standout
Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study
2009
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis
2008
Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study
2004 Standout
Prevention of Venous Thromboembolism
2004 Standout
The immune response in atherosclerosis: a double-edged sword
2006 Standout
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Activation and Regulation of Purinergic P2X Receptor Channels
2011
Prevention of Venous Thromboembolism
2008 Standout
Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital‐based case–control study
2004
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database
2010
Thrombin/inflammation paradigms: A closer look at arterial and venous thrombosis
2004
Time-dependent bias was common in survival analyses published in leading clinical journals
2004
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
IN VITRO EFFECTS OF ANTIPSYCHOTICS ON HUMAN PLATELET ADHESION AND AGGREGATION AND PLASMA COAGULATION
2007 StandoutNobel
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
2003
Deep sequencing and miRNA profiles in alcohol-induced neuroinflammation and the TLR4 response in mice cerebral cortex
2018
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials
2008
Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: Role of drug induced homocysteinemia?
2007
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond
2012
MicroRNA
2017 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Extracellular DNA traps promote thrombosis
2010 Standout
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Statins for primary prevention of venous thromboembolism
2014
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Statins and Blood Coagulation
2004
Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation
2010
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
2003
The Epidemiology of Venous Thromboembolism
2003 Standout
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment tool.
2003
The Epidemiology of Venous Thromboembolism in the Community: Implications for Prevention and Management
2006
Receptors for Purines and Pyrimidines
2012 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Works of Mohammed Mamdani being referenced
Integrating mRNA and miRNA Weighted Gene Co-Expression Networks with eQTLs in the Nucleus Accumbens of Subjects with Alcohol Dependence
2015
Treatment of Heart Failure by a Methanocarba Derivative of Adenosine Monophosphate: Implication for a Role of Cardiac Purinergic P2X Receptors
2010
Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure
2008
Use of Statins and the Subsequent Development of Deep Vein Thrombosis
2001
Cyclo-oxy genase-2 inhibitors versus nonselective, nonsteroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: A population-based cohort study
2004
Intramyocardial VEGF-B 167 Gene Delivery Delays the Progression Towards Congestive Failure in Dogs With Pacing-Induced Dilated Cardiomyopathy
2010